EUVIMEDEUVIMED entdecken
KorrekturOpen Access · CC BY 4.0

Correction: Alarcia-Lacalle et al. Oritavancin Multiple Dosing for Complex Infections: A Pharmacokinetic/Pharmacodynamic Simulation Study. Pharmaceutics 2026, 18, 628

Ana Alarcia-Lacalle iD, Miguel Ángel Morán-Rodríguez iD, Laura Morata iD, Arantxa Isla iD, Andrés Canut-Blasco iD, Alicia Rodríguez-Gascón iD

Pharmaceutics · 24.07.2026 · 18 (8) · 912

DOI: 10.3390/pharmaceutics18080912 ↗

Kurz gefasst

Korrektur in der Zeitschrift Pharmaceutics, online erschienen am 24.07.2026. Verfasst von Ana Alarcia-Lacalle und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacokinetic, Nanotechnology and Gene Therapy Group (PharmaNanoGene), Faculty of Pharmacy, Lascaray Research Centre, University of the Basque Coun…. Die Arbeit nennt 1 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basque Government.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the original published paper [...]

Autor:innen und Institutionen

  • Pharmacokinetic, Nanotechnology and Gene Therapy Group (PharmaNanoGene), Faculty of Pharmacy, Lascaray Research Centre, University of the Basque Country EHU, Paseo de la Universidad n° 7, 01006 Vitoria-Gasteiz, Spain.
  • Infectious Disease Division, Araba University Hospital, Osakidetza Basque Health Service, Francisco Leandro de Viana Kalea, 01009 Vitoria-Gasteiz, Spain.
  • Microbiology, Infectious Disease, Antimicrobial Agents, and Gene Therapy, Bioaraba Health Research Institute, Jose Atxotegi Kalea s/n, 01009 Vitoria-Gasteiz, Spain.
  • Department of Infectious Diseases, Hospital Clínic of Barcelona, University of Barcelona, Carrer de Villarroel, 170, 08036 Barcelona, Spain.
  • Microbiology Service, Araba University Hospital, Osakidetza Basque Health Service, Francisco Leandro de Viana Kalea, 01009 Vitoria-Gasteiz, Spain.

ORCID-Profile: Ana Alarcia-Lacalle, Miguel Ángel Morán-Rodríguez, Laura Morata, Arantxa Isla, Andrés Canut-Blasco, Alicia Rodríguez-Gascón

Förderung

  • Basque Government

Zitieren

APA

Alarcia-Lacalle, A., Morán-Rodríguez, M. Á., Morata, L., Isla, A., Canut-Blasco, A., & Rodríguez-Gascón, A. (2026). Correction: Alarcia-Lacalle et al. Oritavancin Multiple Dosing for Complex Infections: A Pharmacokinetic/Pharmacodynamic Simulation Study. Pharmaceutics 2026, 18, 628. Pharmaceutics, 18(8), 912. https://doi.org/10.3390/pharmaceutics18080912

Vancouver

Alarcia-Lacalle A, Morán-Rodríguez MÁ, Morata L, Isla A, Canut-Blasco A, Rodríguez-Gascón A. Correction: Alarcia-Lacalle et al. Oritavancin Multiple Dosing for Complex Infections: A Pharmacokinetic/Pharmacodynamic Simulation Study. Pharmaceutics 2026, 18, 628. Pharmaceutics. 2026;18(8):912. doi:10.3390/pharmaceutics18080912

BibTeX
@article{AlarciaLacalle2026,
  author = {Alarcia-Lacalle, Ana and Morán-Rodríguez, Miguel Ángel and Morata, Laura and Isla, Arantxa and Canut-Blasco, Andrés and Rodríguez-Gascón, Alicia},
  title = {Correction: Alarcia-Lacalle et al. Oritavancin Multiple Dosing for Complex Infections: A Pharmacokinetic/Pharmacodynamic Simulation Study. Pharmaceutics 2026, 18, 628},
  journal = {Pharmaceutics},
  year = {2026},
  volume = {18},
  number = {8},
  pages = {912},
  doi = {10.3390/pharmaceutics18080912}
}
Kostenlos starten →